of these documents are in Adobe Acrobat Format. If you are unable to open
them on your computer you will need to download the "free to download" Acrobat
Reader from Adobe.)
Antibody Therapy With Autologous Peripheral Blood Stem Cell Transplantation
for Non-Hodgkin’s Lymphoma (CME)
Ivan Aksentijevich, MD, and Ian W. Flinn, MD, PhD
for Acute Leukemia
John M. Burke, MD, Joseph G. Jurcic, MD, and David A. Scheinberg, MD,
Therapy of Leukemia
Stanley R. Riddell, MD, Makoto Murata, MD, Sophia Bryant, MD, PhD, and
Edus H. Warren, PhD, MD
Lymphocyte Infusions to Treat Hematologic Malignancies in Relapse
After Allogeneic Blood or Marrow Transplantation
Leo Luznik, MD, and Ephraim J. Fuchs, MD
of Hematologic Malignancies: The Road to the Future (PDF
Eduardo M. Sotomayor, MD, and Thomas P. Loughran, MD
Best Readings on Hematologic Malignancies
Eduardo M. Sotomayor, MD
Frank Vrionis, MD, PhD
Research Protocols (PDF
Calendar of Events (PDF
Back to the Cancer Journal Index
For comments mail to: email@example.com
of William Wolk is featured in this issue of Cancer Control. Born in 1951 in
Miami, Florida, he showed an early interest in drawing and painting. He spent
one year in drawing study at the Ringling School of Art and Design in Sarasota,
Florida. He also attended the Academy of Fine Arts in Florence, Italy, but after
two weeks he set out on his own for self study in the city’s lovely museums
and churches. From the masterpieces on their walls, he learned the techniques
of the world’s greatest artists. Since 1984, William Wolk has been Artist
in Residence at The Greenbrier, a five-star, five-diamond resort hotel nestled
in the Allegheny Mountains. He is represented in private collections throughout
the world. His Web address is www.williamwolk.com.
Greenbriar Swans. Oil on canvas, 60"x 40".
Elvis. Oil on canvas, 24" x30".
Mist in the
Valley. Oil on canvas, 66"x 36".
Two on a Hill.
Oil on canvas, 24" x36".
Edge of the
Pond. Oil on canvas, 24" x 36".
Oil on canvas, 16" x 20".
Oil on canvas, 36" x 60".
note: Drew M. Pardoll, MD, PhD, co-author of “Advances in Gene Therapy for Malignant
Melanoma,” which was published in the January/February 2002 issue of Cancer
Control, disclosed the following information: Dr Pardoll receives grant/research
support from Cell Genesys, Inc, and from Genencor International, Inc.